THE EFFECT OF MAGNESIUM OXIDE ON HYPERPHOSPHATEMIA IN FEMALE HEMODIALYSIS PATIENTS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

PAKFETRAT MARYAM; SHARIFPOUR SHOKOUH; MALEKMAKAN LEILA; EZZATZADEGAN JAHROMI SHAHROKH; ROOZBEH JAMSHID; ASLANI AMIR

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: WOMENS HEALTH BULLETIN Year:2014 | Volume:1 | Issue:2 Page(s): 0-0

Download Full-Text

View:

178

Download:

112

Cites:

Information Journal Paper

Title

THE EFFECT OF MAGNESIUM OXIDE ON HYPERPHOSPHATEMIA IN FEMALE HEMODIALYSIS PATIENTS

Author(s)

Keywords

HEMODIALYSIS

HYPERPHOSPHATEMIA

PHOSPHORUS

MAGNESIUM OXIDE

Abstract

Background: HYPERPHOSPHATEMIA is a common problem in HEMODIALYSIS patients for which various binders are used to control this problem.Objectives: This study aims to assess the effect of MAGNESIUM OXIDE on controlling serum PHOSPHORUS levels and evaluate its side effects.Patients and Methods: We studied 39 HEMODIALYSIS patients with HYPERPHOSPHATEMIA. Patients were randomly divided into two groups, trial and control. The trial group received MAGNESIUM OXIDE. Its dose was titrated according to weekly magnesium levels that were checked for 4 weeks. Phosphorous was also checked weekly in both groups. Data were analyzed by SPSS 15 software. P-values less than 0.05 were considered significant.Results: A total of 27 males and 12 females with a mean age 54.01 ± 17.20 years were divided into the trial (21 patients) and control (18 patients) groups. Serum phosphorous levels did not significantly decrease (P=0.994). However the mean phosphorous level in females showed significant correlation with time, as a significant quadratic trend throughout time was observed (P=0.001). A significant ascending trend in mean magnesium levels was observed in the trial group compared to the control group at the end of the study (P<0.001).Conclusions: Although MAGNESIUM OXIDE was well tolerated by the study patients and lacked serious complications, it could not decrease phosphorous levels. In order to better assess these results we recommend that larger, multicenter studies with longer follow up that uses other magnesium compounds be designed.

Cites

No record.

References

No record.

Cite

APA: Copy

PAKFETRAT, MARYAM, SHARIFPOUR, SHOKOUH, MALEKMAKAN, LEILA, EZZATZADEGAN JAHROMI, SHAHROKH, ROOZBEH, JAMSHID, & ASLANI, AMIR. (2014). THE EFFECT OF MAGNESIUM OXIDE ON HYPERPHOSPHATEMIA IN FEMALE HEMODIALYSIS PATIENTS. WOMENS HEALTH BULLETIN, 1(2), 0-0. SID. https://sid.ir/paper/347099/en

Vancouver: Copy

PAKFETRAT MARYAM, SHARIFPOUR SHOKOUH, MALEKMAKAN LEILA, EZZATZADEGAN JAHROMI SHAHROKH, ROOZBEH JAMSHID, ASLANI AMIR. THE EFFECT OF MAGNESIUM OXIDE ON HYPERPHOSPHATEMIA IN FEMALE HEMODIALYSIS PATIENTS. WOMENS HEALTH BULLETIN[Internet]. 2014;1(2):0-0. Available from: https://sid.ir/paper/347099/en

IEEE: Copy

MARYAM PAKFETRAT, SHOKOUH SHARIFPOUR, LEILA MALEKMAKAN, SHAHROKH EZZATZADEGAN JAHROMI, JAMSHID ROOZBEH, and AMIR ASLANI, “THE EFFECT OF MAGNESIUM OXIDE ON HYPERPHOSPHATEMIA IN FEMALE HEMODIALYSIS PATIENTS,” WOMENS HEALTH BULLETIN, vol. 1, no. 2, pp. 0–0, 2014, [Online]. Available: https://sid.ir/paper/347099/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops